These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12766064)

  • 21. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma.
    Yamada H; Akagi T; Nakanishi H; Ikeda HO; Kimura Y; Suda K; Hasegawa T; Yoshikawa M; Iida Y; Yoshimura N
    Ophthalmology; 2016 Mar; 123(3):542-51. PubMed ID: 26692299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study.
    Hung KH; Cheng CY; Liu CJ
    J Chin Med Assoc; 2015 Jul; 78(7):418-23. PubMed ID: 25819708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma.
    Cheng HC; Guo CY; Chen MJ; Ko YC; Huang N; Liu CJ
    JAMA Ophthalmol; 2015 Mar; 133(3):269-75. PubMed ID: 25429608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different methods for detecting glaucomatous visual field progression.
    Vesti E; Johnson CA; Chauhan BC
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3873-9. PubMed ID: 12939303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods.
    Kazemian P; Lavieri MS; Van Oyen MP; Andrews C; Stein JD
    Ophthalmology; 2018 Apr; 125(4):569-577. PubMed ID: 29203067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma.
    Wu JH; Moghimi S; Nishida T; Kamalipour A; Liebmann JM; Fazio M; Girkin CA; Zangwill LM; Weinreb RN
    J Glaucoma; 2023 Jul; 32(7):549-555. PubMed ID: 37171991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An objective evaluation of gaze tracking in Humphrey perimetry and the relation with the reproducibility of visual fields: a pilot study in glaucoma.
    Ishiyama Y; Murata H; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8149-52. PubMed ID: 25389198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cerebrovascular reactivity in posterior cerebral arteries in patients with primary open-angle glaucoma.
    Zhang S; Xie Y; Yang J; Tang Y; Li R; Wang N; Zhang C
    Ophthalmology; 2013 Dec; 120(12):2501-2507. PubMed ID: 23816432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between Peripapillary Retinal Nerve Fiber Layer Thickness Measured by Optical Coherence Tomography and Visual Field Severity Indices.
    Kang EM; Hong S; Kim CY; Seong GJ
    Korean J Ophthalmol; 2015 Aug; 29(4):263-9. PubMed ID: 26240511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.
    Musch DC; Lichter PR; Guire KE; Standardi CL
    Ophthalmology; 1999 Apr; 106(4):653-62. PubMed ID: 10201583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial correlation between localized decreases in exploratory visual search performance and areas of glaucomatous visual field loss.
    Senger C; da Silva MJL; De Moraes CG; Messias A; Paula JS
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):153-160. PubMed ID: 30368564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma.
    Rao HL; Kumar AU; Babu JG; Senthil S; Garudadri CS
    Ophthalmology; 2011 Feb; 118(2):249-53. PubMed ID: 20728941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma.
    Janz NK; Wren PA; Lichter PR; Musch DC; Gillespie BW; Guire KE; Mills RP;
    Ophthalmology; 2001 Nov; 108(11):1954-65. PubMed ID: 11713062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of visual field abnormalities in the ocular hypertension treatment study.
    Keltner JL; Johnson CA; Cello KE; Edwards MA; Bandermann SE; Kass MA; Gordon MO;
    Arch Ophthalmol; 2003 May; 121(5):643-50. PubMed ID: 12742841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.
    Keltner JL; Johnson CA; Levine RA; Fan J; Cello KE; Kass MA; Gordon MO
    Arch Ophthalmol; 2005 Sep; 123(9):1201-6. PubMed ID: 16157799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.